Korean Market
OWNR
Yuhan
★

Executive/Major Shareholder Securities Ownership Report Filed - No Content

 
EXCH
Yuhan
★★

Supply Agreement for Cardiomyopathy Treatment API with BridgeBio Pharma

 
OWNR
Yuhan
★

Submission of Insider Ownership Report (Blank)

 
OWNR
Yuhan
★

No Change in Executive/Major Shareholder Holdings

 
EXCH
Yuhan
★

Yuhan Q1 2026 Preliminary: Operating Profit -72.3% QoQ, +2.1% YoY